Schedule 13G ownership disclosure

ONCOGENEX PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 68230A106

Event date: 2014-10-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
882,216
Percent of class
4.1500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-14-000075
Form type
SC 13G
Filer
ACHIEVE LIFE SCIENCES, INC.
CIK
CIK 949858
Filed
Nov 07, 2014
Reporting period
Oct 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub